Mayo Clinic http://www.mayohealth.org
This site maintains a searchable index of drugs currently
available in the US.
National Institutes of Health: http://www.medlineplus.gov
The National Institutes of Health maintain a searchable site
with details about drugs currently available in the US as
well as drugs which are currently under development and seeking
American Society of Health-System Pharmacists http://www.safemedication.com
Website with a search engine to find information about any
drug that you are interested in.
The US governments Food and Drug Administration (FDA) maintains
a website with information on drugs and supplements, as well
as information about what claims a specific product may make:
Tyler's Honest Herbal, by Steven
Foster and Varro E. Tyler (Binghampton, NY: The Hayworth Press,
Two experts on herbs and their medicinal uses provide a fair
and concise summary of the risks and benefits of more than
120 herbal remedies.
The Physician's Desk Reference for Nutritional
Supplements, by Sheldon Saul Hendler Ph.D., M.D., and
David Rorvik. (Montvale, NJ: The Medical Economics Company,
Inc., 2001, 700 pp., $59.95). This frank and science-based
book reviews the scientific evidence for ginkgo biloba and
other herbal remedies.
"Dietary supplements: Nutritional
and legal considerations," by Mary Ellen Camire
and Mark A. Kantor. (Food Technology, vol. 53, no. 7, July
This is a report in a technical journal which summarizes what
scientists currently know about the role of vitamins, herbals
and other dietary supplements in human health.
"Cholinesterase inhibitors: A therapeutic
strategy for Alzheimer's disease," by W. Krall,
J. Sramek, N. Cutler (Annals of Pharmacotherapy, 1999, vol.
33, p. 441-450).
This is a technical article in a scientific journal which
contains a comprehensive review of the class of drugs (cholinesterase
inhibitors) which includes all the drugs currently marketed
in the US as treatment for Alzheimer's disease.
B. Oken and others, "The efficacy
of ginkgo biloba on cognitive function in Alzheimer disease,"
in Archives of Neurology, November 1998, vo. 55, no. 11, pp.
"A placebo-controlled, double-blind,
randomized trial of an extract of ginkgo biloba for dementia,"
by the North American EGb Study Group, in Journal of the American
Medical Association, October 1997, vol. 278, no. 16, pp. 1327-1332.
"The efficacy of ginkgo for elderly
people with dementia and age-associated memory impairment:
new results of a randomized clinical trial," by
M. van Dongen and others, in Journal of the American Geriatric
Society, October 2000, vol. 48, no. 10, pp. 1183-1194.
"A 26-week analysis of a double-blind,
placebo-controlled trial of the ginkgo biloba extract EGb
761 in dementia," by P. Le Bars and others, in
Dementia and Geriatric Cognitive Disorders, July-August 2000,
vol. 11, no. 4, pp. 230-237.